Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

40.35
Delayed Data
As of Jan 20
 +0.18 / +0.45%
Today’s Change
36.81
Today|||52-Week Range
44.50
-0.22%
Year-to-Date
Regeneron Pharmaceuticals Could Be Ready to Rebound
Jan 20 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
MannKind Has a New Plan, but Will It Work?
Jan 18 / MotleyFool.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
Jan 18 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases
Jan 11 / Zacks.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close40.17
Today’s open40.42
Day’s range40.23 - 40.58
Volume988,291
Average volume (3 months)2,456,238
Market cap$103.9B
Dividend yield4.12%
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.60%
Revenue growth (last year)-14.57%
P/E ratio25.4
Price/Sales2.96
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.23-0.37%
GSKGlaxoSmithKline-0.03-0.08%
CELGCelgene-0.96-0.84%
LLYEli Lilly and Co-0.03-0.04%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts


Search for Jobs